ScholarIQanswers from OpenAlex & ORCID
Frank S. Czerwiec
ResearcherPublications, citations & collaboration network
Frank S. Czerwiec is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Frank S. Czerwiec have?
ScholarIQindexed works
Frank S. Czerwiec has 92 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Frank S. Czerwiec have?
ScholarIQcitation count
Frank S. Czerwiec has 8,017 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Frank S. Czerwiec?
ScholarIQh-index
Frank S. Czerwiec has an h-index of 37 in OpenAlex.
What is the i10-index of Frank S. Czerwiec?
ScholarIQi10-index
Frank S. Czerwiec has an i10-index of 53 in OpenAlex.
What is the OpenAlex record for Frank S. Czerwiec?
ScholarIQopenalex
The OpenAlex for Frank S. Czerwiec is on the source record.
What are the most-cited papers on Frank S. Czerwiec?
ScholarIQmost cited works
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
Vicente E. Torres, Arlene B. Chapman, Olivier Devuyst, Ron T. Gansevoort, Jared J. Grantham, Eiji Higashihara, Ronald D. Perrone, Holly B. Krasa, John Ouyang, Frank S. Czerwiec
Tolvaptan, a Selective Oral Vasopressin V <sub>2</sub> -Receptor Antagonist, for Hyponatremia
Robert W. Schrier, Peter Groß, Mihai Gheorghiade, Tomás Berl, Joseph G. Verbalis, Frank S. Czerwiec, Cesare Orlandi
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
Vicente E. Torres, Arlene B. Chapman, Olivier Devuyst, Ron T. Gansevoort, Ronald D. Perrone, Gary G. Koch, John Ouyang, Robert D. McQuade, Jaime D. Blais, Frank S. Czerwiec, Olga Sergeyeva
Vasopressin V <sub>2</sub> -Receptor Blockade With Tolvaptan in Patients With Chronic Heart Failure
Mihai Gheorghiade, Imran Khan Niazi, John Ouyang, Frank S. Czerwiec, Jun‐ichi Kambayashi, Manuela Zampino, Cesare Orlandi
Oral Tolvaptan Is Safe and Effective in Chronic Hyponatremia
Tomás Berl, Friederike Quittnat-Pelletier, Joseph G. Verbalis, Robert W. Schrier, Daniel G. Bichet, John Ouyang, Frank S. Czerwiec